Android
Zerodha Broker (Free Delivery)

India's No. 1 Broker with Best Software Trade @ Flat Rs 20

Open Instant Account
market update arrow Maruti Suzuki to not to get Vitara Brezza produced at Toyota plantarrow Coronavirus vaccine update: UK, Russia to rollout vaccine from next weekarrow SC to Franklin Templeton: Get investors' consent for winding up schemesarrow Committed to engaging with Indian govt to bring Covid-19 vaccine: Pfizerarrow LIVE: Rajinikanth to launch political party, contest Tamil Nadu 2021 pollsarrow World Coronavirus Dispatch: How UK leaped ahead of US, EU to allow vaccinearrow Flipkart to spin-off PhonePe, payments firm to be valued at $5.5 billionarrow Amarinder meets Shah; appeals to Centre, farmers to resolve impasse soonarrow DATA STORY: At 422,943, India's active Covid cases down to 2.3% of global countarrow Steel Authority of India hits 52-week high; stock zooms 55% in one montharrow Optimistic about revival in Q3, says FinMin in monthly economic reviewarrow Optimistic about revival in Q3, says FinMin in monthly economic reviewarrow Farmers' protest LIVE: Parkash Singh Badal returns Padam Vibhushan Awardarrow MARKET LIVE: Broader indices outperform benchmarks; Maruti hits 52-wk higharrow Services sector grows for second straight month, but rate falls in Nov: PMIarrow Cyclone Burevi LIVE: Cyclone to emerge into Gulf of Mannar in 2 hoursarrow HDFC Bank dips 1% as RBI asks to halt digital launches, new credit cardsarrow Matrimony.com rallies 10% after block deals; stock hits fresh 52-week higharrow CLSA sees 46% upside in SBI stock; raises target price to Rs 360arrow CLSA sees 46% upside in SBI stock; raises target price to Rs 360arrow Halt digital launches, stop selling new credit cards: RBI tells HDFC Bankarrow Bharti Infratel extends gain after Airtel hikes stake through open marketarrow Oil prices slip as OPEC+ resume negotiations on output cut extensionarrow Maruti Suzuki trades higher for the 4th straight day, hits over 11-mth higharrow School dropout to highest-paid CEO: MDH's Dharampal Gulati saw it all

PIRAMAL ENTERPRISES LTD.1492.65 70.40 (4.95%)

  • BSE: 590103
  • |
  • NSE: PEL
  • |
  • ISIN NO: INE140A01024
  • |
  • INDUSTRY: Pharmaceuticals
Profile

PEL

Piramal Enterprises Limited or PEL

PEL or Piramal Enterprise, which was also formerly known as Nicholas Piramal, is considered one of the largest pharmaceutical companies in the country. And being a part of Piramal Group, its healthcare division also contributes 50% to the group’s revenue. Additionally, to healthcare, the company has business interests in the sectors of glass manufacturing, real estate, and retail. The Company operates in the two divisions such as h ... ealthcare solutions and the pharma solutions. The PHL is one of the largest custom manufacturing companies that have a global presence in countries such as Asia, North America, and Europe. Currently, the company is operating across many verticals within life sciences, healthcare, and drug delivery systems, financial services, healthcare information management, and contract manufacturing services, and much more.

The Manufacturing facilities:

  • Healthcare solutions– It has headquarters in Mumbai, and the company has manufacturing facilities situated in Baddi in Himachal Pradesh and Mulund in Maharashtra.
  • Pharma solutions– The manufacturing units of PHL are located at Mahad and Thane in Maharashtra, and Ennore in Tamil Nadu, and Digwal in Andhra Pradesh, and Pithampur in MP or Madhya Pradesh, and Morpeth, Grangemouth, Huddersfield and Billingham in the U.K. and lastly, Torcan in Canada.

Some of the Products and Services:

  • Pharma Solutions– Under this segment, the division is engaged in the manufacturing of API and formulations in about 9 therapeutic areas. Also, the company operates one of the leading custom manufacturing businesses worldwide, and due to this, the PHL offers a complete lifecycle partnership to small or virtual and big pharma. It also provides services such as clinical phase APIs, clinical phase formulations, and commercial APIs. This division also offers packaging solutions.
  • Healthcare solutions– Under this segment, the PHL has developed multi-ingredient formulations and the single–ingredients products.
Also, PHL has acquired US-based RxElite Holdings and the inhalation anesthetic gas distribution arm of the RxElite. This acquisition gives Piramal ownership of the Holdings' sales and distribution network in the US.

Some of the Milestones:

  • 2011:
  • The Company's Solutions manufacturing site at Grangemouth, Scotland became the world’s first contract supplier at a commercial scale for the ADCs.
  • The Fortune 500 ranks Piramal Healthcare in the top–50 largest organizations across India.
  • The Company is ranked 5 out of the top 10 pharmaceutical contract manufacturers worldwide, and it is 1st in India by the ‘UN Conference on Trade and Development’s World Investment Report in 2011’.
  • 2012:
  • The Company was renamed to Piramal Enterprises Limited.
  • Also, it acquires the molecular imaging development portfolio of the Bayer Pharma.
  • The Company received Platinum Award for the Manufacturing Excellence by Frost & Sullivan in partnership with the Economic Times in 2012.
  • 2013:
  • Piramal Water or Sarvajal was honored with ‘Enabling Technology Award of the Year 2013’ by the Frost & Sullivan.

Read More
Key Data
  • Market cap 28962.00 CR.
  • Book value 935.57
  • Stock P/E 162
  • Dividend Yield 1.09%
  • ROCE 6.85%
  • ROE 0.72%
  • Sales Growth (3Y) 3.86%
  • Face Value (3Y) 2.00
Trend Analysis
  • Short Term Trend :
    Up
  • Medium Term Trend :
    Up
  • Long Term Trend :
    Not Clear

Are you friends with trend?

There is a saying in stock market, "Trend is your best friend"

It means, a good trader doesn't place his money against the trend. Many new traders lose money because they are trying to catch trend reversals but seasoned traders wait for a clear trend to emerge before taking the trade in the direction of trend.

Day Technicals

What is Opening Range Breakout?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

NR7

What is NR7 trading strategy?

Narrow Range trading strategy or NR7 Trading strategy is a breakout based method which assumes that the price of security trends up or down after a brief consolidation in a narrow range.

Opening Price clues

How to use Opening Price Clues in your trades?

If the stock has same open and high after it has traded for some time, it implies there was a consistent selling pressure that didn't allow the stock to move higher from the opening price. Similarly, if the stock has same open and low price, it implies there was a consistent buying intent that kept the stock price above the opening price.

Day High Low Range
TIME LOWEST HIGHEST
10 AM 1426.00 1450.00
11 AM 1426.00 1458.00
12 PM 1426.00 1474.90
1 PM 1426.00 1480.00
2 PM 1426.00 1480.00
3 PM 1426.00 1500.00
Japanese Candlestick Patterns
Candle Pattern 1 :None
Candle Pattern 2 : None
Candle Pattern 3 :None
Candlestick Price Action
Higher High Higher Low
Pivot Points
Name S4 S3 S2 S1 Pivot Points R1 R2 R3 R4
classic 1263.58 1318.53 1373.48 1397.87 1428.43 1452.82 1483.38 1538.33 1593.28
woodie's 1287.42 1342.37 1373.21 1397.32 1428.16 1452.28 1483.11 1507.22 1562.18
fibonacci - 1373.48 1394.46 1407.44 1428.43 1449.42 1462.40 1483.38 -
camarilla 1392.03 1407.14 1412.18 1417.21 -- 1427.29 1432.32 1437.36 1452.47
Past Performance & Moving Averages
Day’s LOW HIGH RANGE SMA PERFORMANCE Nifty
10 DAY 1371.25
1459.00
1408.03 3.05 % 2.25 %
20 DAY 1285.20
1478.75
1390.40 2.34 % 4.01 %
50 DAY 1178.55
1478.75
1328.37 13.39 % 10.93 %
100 DAY 1178.55
1594.00
1370.73 1.59 % 14.80 %
200 DAY 606.85
1633.90
1232.21 68.24 % 48.91 %
YTD 606.85
1727.95
1273.92 -5.48 % 7.80 %
52 Week 606.85
2126.25
1457.70 -14.74 % 9.87 %

Why are moving Averages important in technical Analysis?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

Gaps On Day Chart
Unfilled Gap Up On 2020-06-19
1047.00 ~ 1044.95 SUPPORT
Unfilled Gap Up On 2020-06-01
985.10 ~ 985.00 SUPPORT
Unfilled Gap Down On 2019-04-15
2695.00 ~ 107000.00 RESISTANCE
Unfilled Gap Down On 2019-04-11
2695.00 ~ 107000.00 RESISTANCE
Unfilled Gap Down On 2019-03-28
2708.00 ~ 112000.00 RESISTANCE
Unfilled Gap Down On 2018-09-11
3057.20 ~ 126000.00 RESISTANCE
Unfilled Gap Down On 2018-09-04
3126.80 ~ 126500.00 RESISTANCE
Industry Growth Rate

In Last 1 Year the industry has grown by 12.29 %

In Last 5 Year the industry has grown by 13.62 %

Peer comparison

Sales

COMPANY NAME201420152016201720182019
PEL4503.005123.006342.008504.0010631.0013215.00
SUNPHARMA16080.0027392.0028487.0031578.0026489.0029066.00
LUPIN11286.0012770.0014256.0017367.0015797.0016718.00
CIPLA10173.0011345.0013790.0014394.0015156.0016362.00
AUROPHARMA8089.0012103.0013772.0014910.0016463.0019564.00
Total 10026.20 13746.60 15329.40 17350.60 16907.20 18985.00

Financial

LAST FISCAL CURRENT GROWTH 10 YEAR CAGR
S.NO. COMPANY NAME MARKET CAP CMP BOOK VALUE EPS STOCK P/E ROE ICR REVENUE NET PROFIT NPM REVENUE NET PROFIT REVENUE NET PROFIT
1 SUN PHARMACEUTICAL INDUSTRIES LTD. 130779.54 545.00 98.33 11.11 38.37 11.10 11.45% 29066.00 2665.00 9.17% 9.73% 27.15% 21.39% 3.90%
2 MARKSANS PHARMA LTD. 92969.02 22.65 11.85 1.87 10.83 1.85 13.20% 1000.00 76.00 7.60% 9.53% 130.30% 10.88%
3 MOREPEN LABORATORIES LTD. 71575.87 15.90 6.43 0.64 23.05 0.32 34.00% 769.00 29.00 3.77% 26.69% 15.56%
4 NEULAND LABORATORIES LTD. 50071.35 390.75 542.16 12.74 36.68 1.23 3.63% 667.00 16.00 2.40% 26.57% 33.33% 8.07% 2.92%
5 GUFIC BIOSCIENCES LTD. 41419.69 53.30 10.85
6 DIVI'S LABORATORIES LTD. 96626.02 3641.40 266.77 50.96 38.52 25.53 374.60% 4946.00 1353.00 27.36% 27.11% 54.28% 15.41% 12.49%
7 DR.REDDY'S LABORATORIES LTD. 80510.42 4846.00 852.69 117.47 26.67 23.49 35.71% 15448.00 1950.00 12.62% 8.17% 105.91% 8.45%
8 RPG LIFE SCIENCES LTD. 41788.21 252.45 105.02
9 SMS PHARMACEUTICALS LTD. 34236.68 40.25 42.07 4.73 8.97 5.00 7.50% 465.00 40.00 8.60% 0.43% 25.00%
10 CIPLA LTD. 61104.30 758.15 209.71 18.96 23.60 9.49 18.43% 16362.00 1528.00 9.34% 7.96% 8.29% 12.67% 7.08%
11 TORRENT PHARMACEUTICALS LTD. 45441.06 2684.05 323.66 25.78 77.62 5.13 3.86% 7673.00 436.00 5.68% 28.96% 16.89% 9.01%
12 PIRAMAL ENTERPRISES LTD. 32088.12 1422.65 823.58 70.51 20.69 39.81 1.61% 13215.00 1473.00 11.15% 24.31% 15.08% 16.64%
13 LUPIN LTD. 41417.53 914.05 384.76 13.40 53.92 6.74 9.28% 16718.00 607.00 3.63% 5.83% 141.83% 16.04% 1.92%
14 NECTAR LIFESCIENCES LTD. 29495.44 13.16 49.89 2.12 6.56 2.18 1.78% 2779.00 48.00 1.73% 48.29% 14.38%
15 AUROBINDO PHARMA LTD. 52084.75 889.35 206.07 40.36 12.59 40.08 15.03% 19564.00 2365.00 12.09% 18.84% 20.53% 37.21%
16 Alkem Laboratories Ltd 33613.48 2799.95 501.34 63.61 37.53 31.71 20.36% 7357.00 761.00 10.34% 14.94% 20.60%
17 ABBOTT INDIA LTD. 32448.50 15218.20 1004.00
18 CADILA HEALTHCARE LTD. 46189.11 451.00 90.85 18.05 15.05 18.13 15.32% 13166.00 1849.00 14.04% 10.59% 4.11% 16.49% 19.83%
19 GLAXOSMITHKLINE PHARMACEUTICALS LTD. 26269.01 1551.00 138.61 26.29 52.38 2.63 581.00% 3128.00 445.00 14.23% 8.95% 26.78%
20 KILITCH DRUGS (INDIA) LTD. 13893.00 89.90 98.74 2.49 51.55 0.25 11.22% 82.40 3.83 4.65% 61.70%
Sales

What is Sales Trend ?

Sales trend is a methodology to understand sales results which helps in understanding the trends of the market over a specific period of time. Sales results are an indicative of the sales patterns followed by the customer over a time period.

Profitability

What is Profit & EPS Trend ?

EPS Trends was initially built in late 2015 when I was just getting into frontend development. Coming from a background in Rails, I was frustrated with how many decisions you had to make early on as a javascript developer.

Net Profit
EPS

What is EBITDA Margin & EBIT Margin ?

Corporate accounting is required to adhere to the standards and practices collectively referred to as the generally accepted accounting principles. EBITDA is an excellent way for corporate accountants to start compiling data, but it should not be considered an absolute result. This is due to the fact that many consider EBITDA more of a broad stroke than a definitive form of accounting practice.

EBITDA Margin
EBIT Margin
NPM
Cash Flow

Why is the Cash Flow Analysis important?

A business needs cash to pay its expenses, to pay bank loans, to pay taxes and to purchase new assets. A cash flow report determines whether a business has enough cash to do exactly this.

Operating Activities
Financing Activities
Investing Activities
Financial Health

What Is Financial Health?

Financial health is a term used to describe the state of one's personal monetary affairs. There are many dimensions to financial health, including the amount of savings you have, how much you’re putting away for retirement, and how much of your income you are spending on fixed or non-discretionary expenses.

Debt to Equity
Piotroski Score
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

What Is the Piotroski Score?

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a firm's financial position.

Altman Z Score (Mfg Company)
  • 1.51
    Distress (< 1.81)
  • Caution (>1.81 < 2.99)
  • Safe (3 & above)
Altman Z Score (Non-Mfg Company)
  • Distress ( < 1.23)
  • Caution (>1.23 < 2.6)
  • 3.96
    Safe (2.6 & above)
Valuation

What Is Valuation?

Valuation is the analytical process of determining the current (or projected) worth of an asset or a company. There are many techniques used for doing a valuation. An analyst placing a value on a company looks at the business's management, the composition of its capital structure, the prospect of future earnings, and the market value of its assets, among other metrics.

PEL: Future
TRADING SYMBOL OI VOLUME LAST PRICE LOT SIZE EXPIRY DATE
PEL20DECFUT 3513950.00 3777400.00 1501.85 550 2020-12-31
PEL21JANFUT 23100.00 40700.00 1503.45 550 2021-01-28
PEL21FEBFUT 0.00 0.00 0.00 550 2021-02-25
ROLLOVER COST: 0.11% (INR 1.60)
ROLLOVER%:0.65%
What is the significance of Rollover data?

Rollover in an important data point and should be analyzed in the expiry week. Rollover involves carry forwarding of ‘futures’ positions from one series (which is nearing expiry date) to the next one.

Rollover percentage actually indicates whether the traders are willing to carry forward their existing. positions (long or short) to the next series or not. Generally, the rollover figures alone will not indicate which direction traders are betting on. You should also check whether absolute open interest is increasing or decreasing over expiries

What is Options Max Pain Theory?

Options Max Pain Theory suggests,

“On option expiration day, the underlying stock price often moves toward a point that brings maximum loss to option buyers.”

Ratio Analysis

The Bank was incorporated in the year 2004 by Rana Kapoor and Late Ashok Kapur, which is a new age private sector bank. And since the inception of the bank has fructified into a “Full-Service Commercial Bank,” it has steadily built Corporate and Institutional Banking, Financial Markets, Investment Banking, Corporate Finance, Branch Banking, Business and Transaction Banking, and Wealth Management business lines across the whole country.

It is well-equipped to offer a spectrum of products and services to all the corporate and retail customers.

Read More
Bulk Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
PEL 2018-01-29 EAST BRIDGE CAPITAL MASTER FUND 1 LIMITED P 2533910.00 2804.00
PEL 2018-01-29 MORGAN STANLEY ASIA (SINGAPORE) PTE S 2533910.00 2804.00
PEL 2010-09-08 CAVAAL FININVEST PVT LTD P 7712677.00 511.00
PEL 2010-09-08 SAVOY FINANCE AND INVESTMENTS PRIVATE LIMITED S 6308533.00 511.00
PEL 2010-09-08 THE SWASTIK SAFE DEPOSIT & INVESTMENTS LIMITED S 1354537.00 511.00
PEL 2010-09-07 CAVAAL FININVEST PVT LTD P 7500000.00 511.00
PEL 2010-09-07 THE SWASTIK SAFE DEPOSIT & INVESTMENTS LIMITED S 7500000.00 511.00
PEL 2010-09-06 ANAND AJAY PIRAMAL S 2736133.00 514.00
PEL 2010-09-06 NANDINI AJAY PIRAMAL S 3856277.00 514.00
PEL 2010-09-06 PIRAMAL MANAGEMENTSERVICES PRIVATE LIMITED P 6592410.00 514.00
PEL 2010-09-03 BMK LABORATORIES PRIVATE LIMITED P 7784677.00 505.00
PEL 2010-09-03 PHL HOLDINGS PRIVATE LIMITED S 7784677.00 505.00
PEL 2010-09-02 BMK LABORATORIES PRIVATE LIMITED P 12000000.00 510.00
PEL 2010-09-02 PHL HOLDINGS PRIVATE LIMITED S 12000000.00 510.00
PEL 2010-09-01 BMK LABORATORIES PRIVATE LIMITED P 9000000.00 501.00
PEL 2010-09-01 PHL HOLDINGS PRIVATE LIMITED S 9000000.00 501.00
PEL 2010-08-31 BMK LABORATORIES PRIVATE LIMITED P 9000000.00 488.00
PEL 2010-08-31 PHL HOLDINGS PRIVATE LIMITED S 9000000.00 488.00
PEL 2010-08-30 PARAMOUNT PHARMA PRIVATE LIMITED P 10000000.00 491.00
PEL 2010-08-30 PHL HOLDINGS PRIVATE LIMITED S 10000000.00 491.00
PEL 2010-08-27 PARAMOUNT PHARMA PRIVATE LIMITED P 10000000.00 499.00
PEL 2010-08-27 PHL HOLDINGS PRIVATE LIMITED S 10000000.00 499.00
PEL 2010-08-26 PARAMOUNT PHARMA PRIVATE LIMITED P 10000000.00 501.00
PEL 2010-08-26 PHL HOLDINGS PRIVATE LIMITED S 10000000.00 501.00
PEL 2010-08-25 PARAMOUNT PHARMA PVT LTD P 10000000.00 525.00
PEL 2010-08-25 PHL HOLDING PVT LTD S 10000000.00 525.00
PEL 2010-05-21 CROSSEAS CAPITAL SERVICES PRIVATE LIMITED S 1200343.00 557.51
PEL 2010-05-21 CROSSEAS CAPITAL SERVICES PRIVATE LIMITED P 1199450.00 557.99
PEL 2010-05-21 OPG SECURITIES P LTD S 1071226.00 557.78
PEL 2010-05-21 OPG SECURITIES P LTD P 1071226.00 557.47
PEL 2008-07-30 THE SWASTIK SAFE DEPOSIT P 1390000.00 315.00
PEL 2008-07-30 URVI ASHOK PIRAMAL S 1390000.00 315.00
PEL 2007-08-16 NANDAN ASHOK PIRAMAL S 1066669.00 260.00
PEL 2007-08-16 PIRAMAL ENTERPRISES EXECUTIVE TRUST P 2425000.00 260.00
PEL 2007-08-16 PIRAMAL POLYMERS LTD. P 1335678.00 260.00
PEL 2007-08-16 RAJEEV PIRAMAL S 1060328.00 260.00
PEL 2005-03-18 COMGEST S.A. S 1500000.00 250.00
PEL 2005-03-18 FIRST STATE INVESTMENTS P 1500000.00 250.00
PEL 2005-02-03 KOTAK MAHINDRA GLOBAL IND S 290000.00 278.36
PEL 2005-02-03 KOTAK MAHINDRA GLOBAL IND P 290000.00 279.74
Block Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
PEL 2018-03-23 BAOBAB GLOBAL FUND LTD P 244660.00 2480.00
PEL 2018-03-23 COPTHALL MAURITIUS INVESTMENT LIMITED S 244660.00 2480.00
PEL 2016-02-29 NEW INDIA INVESTMENT COMPANY MAURITIUS LIMITED S 557489.00 886.60
PEL 2016-02-29 NEW INDIA INVESTMENT TRUST PLC P 557489.00 886.60
PEL 2015-06-18 CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED P 226025.00 940.00
PEL 2015-06-18 MORGAN STANLEY ASIA (SINGAPORE) PTE S 226025.00 940.00
PEL 2015-03-17 THE AJAY G. PIRAMAL FOUNDATION S 123000.00 838.00
PEL 2015-03-17 PIRAMAL MANAGEMENT SERVICES PRIVATE LIMITED P 123000.00 838.00
PEL 2011-06-23 THE AJAY G. PIRAMAL FOUNDATION S 250000.00 367.00
PEL 2011-06-23 BMK LABORATORIES PRIVATE LIMITED P 250000.00 367.00
PEL 2010-09-08 SAVOY FINANCE AND INVESTMENTS PRIVATE LIMITED S 6308533.00 511.00
PEL 2010-09-08 THE SWASTIK SAFE DEPOSIT & INVESTMENTS LIMITED S 1354537.00 511.00
PEL 2010-09-08 CAVAAL FININVEST PVT LTD P 1354537.00 511.00
PEL 2010-09-08 CAVAAL FININVEST PVT LTD P 6308533.00 511.00
PEL 2010-09-07 CAVAAL FININVEST PVT LTD P 7500000.00 511.00
PEL 2010-09-07 THE SWASTIK SAFE DEPOSIT & INVESTMENTS LIMITED S 7500000.00 511.00
PEL 2010-09-06 ANAND AJAY PIRAMAL S 2736133.00 514.00
PEL 2010-09-06 NANDINI AJAY PIRAMAL S 3856277.00 514.00
PEL 2010-09-06 PIRAMAL MANAGEMENTSERVICES PRIVATE LIMITED P 3856277.00 514.00
PEL 2010-09-06 PIRAMAL MANAGEMENTSERVICES PRIVATE LIMITED P 2736133.00 514.00
PEL 2010-09-06 BMK LABORATORIES PRIVATE LIMITED P 500000.00 514.00
PEL 2010-09-06 PHL HOLDINGS PRIVATE LIMITED S 500000.00 514.00
PEL 2010-09-03 SWATI AJAY PIRAMAL S 446686.00 505.00
PEL 2010-09-03 PIRAMAL MANAGEMENTSERVICES PRIVATE LIMITED P 446686.00 505.00
PEL 2010-09-03 PIRAMAL MANAGEMENTSERVICES PRIVATE LIMITED P 208875.00 505.00
PEL 2010-09-03 AJAY G PIRAMAL HUF S 208875.00 505.00
PEL 2010-09-03 BMK LABORATORIES PRIVATE LIMITED P 7784677.00 505.00
PEL 2010-09-03 PHL HOLDINGS PRIVATE LIMITED S 7784677.00 505.00
PEL 2010-09-02 PHL HOLDINGS PRIVATE LIMITED S 3000000.00 510.00
PEL 2010-09-02 PHL HOLDINGS PRIVATE LIMITED S 9000000.00 510.00
PEL 2010-09-02 BMK LABORATORIES PRIVATE LIMITED P 3000000.00 510.00
PEL 2010-09-02 BMK LABORATORIES PRIVATE LIMITED P 9000000.00 510.00
PEL 2010-09-01 BMK LABORATORIES PRIVATE LIMITED P 9000000.00 501.00
PEL 2010-09-01 PHL HOLDINGS PRIVATE LIMITED S 9000000.00 501.00
PEL 2010-08-31 BMK LABORATORIES PRIVATE LIMITED P 9000000.00 488.00
PEL 2010-08-31 PHL HOLDINGS PRIVATE LIMITED S 9000000.00 488.00
PEL 2010-08-30 PARAMOUNT PHARMA PRIVATE LIMITED P 10000000.00 491.00
PEL 2010-08-30 PHL HOLDINGS PRIVATE LIMITED S 10000000.00 491.00
PEL 2010-08-27 PHL HOLDINGS PRIVATE LIMITED S 10000000.00 499.00
PEL 2010-08-27 PARAMOUNT PHARMA PRIVATE LIMITED P 10000000.00 499.00
PEL 2010-08-26 PHL HOLDINGS PRIVATE LIMITED S 10000000.00 501.00
PEL 2010-08-26 PARAMOUNT PHARMA PRIVATE LIMITED P 10000000.00 501.00
PEL 2010-08-25 PARAMOUNT PHARMA PVT LTD P 10000000.00 525.00
PEL 2010-08-25 PHL HOLDING PVT LTD S 10000000.00 525.00
PEL 2008-07-30 THE SWASTIK SAFE DEPOSIT AND INV LTD P 1390000.00 315.00
PEL 2008-07-30 URVI ASHOK PIRAMAL S 1390000.00 315.00
PEL 2007-08-16 PIRAMAL POLYMERS LTD. P 1335678.00 260.00
PEL 2007-08-16 PIRAMAL ENTERPRISES EXECUTIVE TRUST P 2425000.00 260.00
PEL 2007-08-16 URVI ASHOK PIRAMAL S 694485.00 260.00
PEL 2007-08-16 RAJEEV PIRAMAL S 1060328.00 260.00
PEL 2007-08-16 HARSHVARDHAN A. PIRAMAL S 691696.00 260.00
PEL 2007-08-16 RESHMA H. PIRAMAL S 247500.00 260.00
PEL 2007-08-16 NANDAN ASHOK PIRAMAL S 1066669.00 260.00
Dividend history
Ex Date Amount
2019-07-18 28.00
2018-07-19 25.00
2017-07-21 21.00
2016-03-17 17.50
2015-07-28 20.00
2014-07-15 52.50
2013-07-15 17.50
2012-07-09 17.50
2011-07-28 6.00
2011-07-28 6.00
2010-06-29 5.40
2009-06-05 4.20
2008-06-16 4.20
2005-06-24 3.00
2001-06-11 7.00
Bonus Data
Company Name Split Date From Value To Value
Split Data
Company Name Split Date From Value To Value